Article info

PDF

Extended report
Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis

Authors

  1. Correspondence to Professor Ronald F van Vollenhoven, Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm 17176, Sweden; ronald.van.vollenhoven{at}ki.se
View Full Text

Citation

van Vollenhoven RF, Østergaard M, Leirisalo-Repo M, et al
Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis

Publication history

  • Received April 10, 2014
  • Revised March 17, 2015
  • Accepted March 25, 2015
  • First published April 14, 2015.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

  • Lay summary

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.